Laminin fragments have been detected in serological exams of head and neck squamous cell carcinoma patients [37], corroborating the hypothesis that tumor-mediated enzymatic degradation can promote laminin peptides release. This evidence concerns the gene LAMB2 and head and neck squamous cell carcinoma.